Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision label was updated to v3.6.6, indicating a minor update to the page's versioning. This change does not alter the study details or user-facing content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a small backend or UI update without changes to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a behind-the-scenes update; no study information or visible content is altered.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the study record, indicating a new release of the page. This typically reflects minor edits or corrections to the record without changing the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedThe site's software revision was updated from v3.6.0 to v3.6.2, signaling a minor platform update. This likely reflects backend improvements or bug fixes without altering the public study details shown on the page.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and an explicit recruitment status line ('No longer looking for participants'), and standardizes the Intervention/Treatment label while updating the page revision tag to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.